X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (74) 74
index medicus (73) 73
female (52) 52
oncology (42) 42
breast cancer (36) 36
mutation (32) 32
breast neoplasms - genetics (29) 29
genetic aspects (28) 28
cancer (25) 25
adult (20) 20
middle aged (19) 19
polymorphism, single nucleotide (19) 19
proto-oncogene proteins c-mdm2 - genetics (19) 19
research (18) 18
male (17) 17
tumors (17) 17
aged (15) 15
aged, 80 and over (15) 15
gene (15) 15
health aspects (15) 15
promoter regions, genetic (15) 15
breast neoplasms - drug therapy (14) 14
gene expression (14) 14
genes (14) 14
polymorphism (14) 14
biochemistry (13) 13
chemotherapy (13) 13
expression (13) 13
gene mutations (13) 13
genetic predisposition to disease (13) 13
p53 (13) 13
risk factors (13) 13
breast neoplasms - metabolism (12) 12
breast neoplasms - pathology (12) 12
cancer research (12) 12
chemistry (12) 12
metastasis (12) 12
analysis (11) 11
beer (11) 11
cell biology (11) 11
compositions or test papers therefor (11) 11
condition-responsive control in microbiological orenzymological processes (11) 11
enzymology (11) 11
mdm2 (11) 11
measuring or testing processes involving enzymes, nucleicacids or microorganisms (11) 11
metallurgy (11) 11
microbiology (11) 11
mutation or genetic engineering (11) 11
processes of preparing such compositions (11) 11
snp309 (11) 11
spirits (11) 11
vinegar (11) 11
wine (11) 11
amplification (10) 10
biochemistry & molecular biology (10) 10
cell line, tumor (10) 10
cohort studies (10) 10
gene expression regulation, neoplastic (10) 10
genomics (10) 10
mutations (10) 10
neoplasms - genetics (10) 10
ovarian cancer (10) 10
prognosis (10) 10
research article (10) 10
tumor proteins (10) 10
tumor suppressor protein p53 - genetics (10) 10
association (9) 9
breast-cancer (9) 9
dna mutational analysis (9) 9
doxorubicin (9) 9
medicine (9) 9
multidisciplinary sciences (9) 9
p53 protein (9) 9
accelerates tumor-formation (8) 8
article (8) 8
dna (8) 8
genomes (8) 8
medical and health sciences (8) 8
medicin och hälsovetenskap (8) 8
neoplasms (8) 8
patients (8) 8
resistance (8) 8
biomedicine (7) 7
breast (7) 7
case-control studies (7) 7
clinical medicine (7) 7
endometrial cancer (7) 7
genetic research (7) 7
mutagenesis (7) 7
oncology, experimental (7) 7
ovarian-cancer (7) 7
postmenopausal women (7) 7
rna (7) 7
single nucleotide polymorphism (7) 7
single nucleotide polymorphisms (7) 7
treatment outcome (7) 7
anthracyclines (6) 6
apoptosis (6) 6
base sequence (6) 6
cancer and oncology (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 10/2011, Volume 117, Issue 20, pp. 4617 - 4622
BACKGROUND: Patients with metastatic poorly differentiated endocrine carcinoma (PDEC) usually have a short survival. The chemotherapy combination of cisplatin... 
second‐line and temozolomide | chemotherapy | neuroendocrine cancer | PDEC | second-line and temozolomide | TRACT | PHASE-II TRIAL | ETOPOSIDE | NEUROENDOCRINE TUMORS | CISPLATIN | ONCOLOGY | SMALL-CELL CARCINOMA | Capecitabine | Humans | Middle Aged | DNA Repair Enzymes - genetics | Male | Antineoplastic Agents, Alkylating - administration & dosage | DNA Repair - genetics | Promoter Regions, Genetic - genetics | Bevacizumab | Cisplatin - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Fluorouracil - administration & dosage | Tumor Suppressor Proteins - genetics | Dacarbazine - analogs & derivatives | Adult | Female | Carcinoma, Neuroendocrine - chemistry | Retrospective Studies | Dacarbazine - administration & dosage | Drug Administration Schedule | Fluorouracil - analogs & derivatives | Biomarkers, Tumor - analysis | Carcinoma, Neuroendocrine - drug therapy | Deoxycytidine - administration & dosage | Kaplan-Meier Estimate | Carcinoma, Neuroendocrine - genetics | Etoposide - administration & dosage | Treatment Outcome | DNA Methylation - genetics | Disease Progression | Disease-Free Survival | DNA Modification Methylases - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Carcinoma, Neuroendocrine - pathology | Aged | Deoxycytidine - analogs & derivatives | Salvage Therapy - methods | Endocrine gland cancer | Care and treatment | Dosage and administration | Temozolomide | Research | Carcinoma | Medical treatment | Medical services | Etoposide | Patients | Survival | Cisplatin | Metastases | Chemotherapy | Methylation | Cancer | Index Medicus | Abridged Index Medicus | temozolomide | second-line | Medical and Health Sciences | Medicin och hälsovetenskap | MEDICIN | MEDICINE
Journal Article
International Journal of Urology, ISSN 0919-8172, 10/2012, Volume 19, Issue 10, pp. 966 - 966
Journal Article
Nature Medicine, ISSN 1078-8956, 07/2015, Volume 21, Issue 7, pp. 751 - 759
Journal Article
by Nik-Zainal, Serena and Davies, Helen and Staaf, Johan and Ramakrishna, Manasa and Glodzik, Dominik and Zou, Xueqing and Martincorena, Inigo and Alexanov, Ludmil B and Martin, Sancha and Wedge, David C and van Loo, Peter and Ju, Young Seok and Smid, Marcel and Brinkman, Arie B and Morganella, Sano and Aure, Miriam R and Lingjærde, Ole Christian and Langerød, Anita and Ringnér, Markus and Ahn, Sung-Min and Boyault, Sanine and Brock, Jane E and Broeks, Annegien and Butler, Adam and Desmedt, Christine and Dirix, Luc and nov, Serge and Fatima, Aquila and Foekens, John A and Gerstung, Moritz and Hooijer, Gerrit K. J and Jang, Se Jin and Jones, David R and Kim, Hyung-Yong and King, Tari A and Krishnamurthy, Savitri and Lee, Hee Jin and Lee, Jeong-Yeon and Li, Yilong and McLaren, Stuart and Menzies, Anew and Mustonen, Ville and O'Meara, Sarah and Pauporté, Iris and Pivot, Xavier and Purdie, Colin A and Raine, Keiran and Ramakrishnan, Kamna and Roíguez-González, F. Germán and Romieu, Gilles and Sieuwerts, Anieta M and Simpson, Peter T and Shepherd, Rebecca and Stebbings, Lucy and Stefansson, Olafur A and Teague, Jon and Tommasi, Stefania and Treilleux, Isabelle and van den Eynden, Gert G and Vermeulen, Peter and Vincent-Salomon, Anne and Yates, Lucy and Caldas, Carlos and van't Veer, Laura and Tutt, Anew and Knappskog, Stian and Tan, Benita Kiat Tee and Jonkers, Jos and Borg, Åke and Ueno, Naoto T and Sotiriou, Christos and Viari, Alain and Futreal, P. Anew and Campbell, Peter J and Span, Paul N and van Laere, Steven and Lakhani, Sunil R and Eyfjord, Jorunn E and Thompson, Alastair M and Birney, Ewan and Stunnenberg, Henik G and van de Vijver, Marc J and Martens, John W. M and Børresen-Dale, Anne-Lise and Richardson, Anea L and Kong, Gu and Thomas, Gilles and Stratton, Michael R and Los Alamos National Lab. (LANL), Los Alamos, NM (United States) and Onkologi och Patologi, MV and Familial Breast Cancer and Lund University and MEMEG and Oncology and Pathology, MV and BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation and Lunds universitet and Familjär bröstcancer
Nature, ISSN 0028-0836, 2016, Volume 534, Issue 7605, pp. 47 - +
Journal Article
by Alexanov, Ludmil B and Nik-Zainal, Serena and Wedge, David C and Aparicio, Samuel A. J. R and Behjati, Sam and Biankin, Anew V and Bignell, Graham R and Bolli, Niccolò and Borg, Ake and Børresen-Dale, Anne-Lise and Boyault, Sanine and Burkhardt, Birgit and Butler, Adam P and Caldas, Carlos and Davies, Helen R and Desmedt, Christine and Eils, Roland and Eyfjörd, Jórunn Erla and Foekens, John A and Greaves, Mel and Hosoda, Fumie and Hutter, Barbara and Ilicic, Tomislav and Imbeaud, Sanine and Imielinsk, Marcin and Jäger, Natalie and Jones, David T. W and Jones, David and Knappskog, Stian and Kool, Marcel and Lakhani, Sunil R and López-Otín, Carlos and Martin, Sancha and Munshi, Nikhil C and Nakamura, Hiromi and Northcott, Paul A and Pajic, Marina and Papaemmanuil, Elli and Paradiso, Angelo and Pearson, John V and Puente, Xose S and Raine, Keiran and Ramakrishna, Manasa and Richardson, Anea L and Richter, Julia and Rosenstiel, Philip and Schlesner, Matthias and Schumacher, Ton N and Span, Paul N and Teague, Jon W and Totoki, Yasushi and Tutt, Anew N. J and Valdés-Mas, Rafael and van Buuren, Marit M and van 't Veer, Laura and Vincent-Salomon, Anne and Waddell, Nicola and Yates, Lucy R and Zucman-Rossi, Jessica and Futreal, P. Anew and McDermott, Ultan and Lichter, Peter and Meyerson, Matthew and Grimmond, Sean M and Siebert, Reiner and Campo, Elías and Shibata, Tatsuhiro and Pfister, Stefan M and Campbell, Peter J and Stratton, Michael R and Claviez, Alexander and Rosenwald, Aneas and Borkhardt, Arndt and Brors, Benedikt and Radlwimmer, Bernhard and Lawerenz, Chris and Lopez, Cristina and Langenberger, David and Karsch, Dennis and Lenze, Dido and Kube, Dieter and Leich, Ellen and Richter, Gesine and Korbel, Jan and Hoell, Jessica and Eils, Jürgen and Hezaveh, Kebriah and Trümper, Lorenz and Rosolowski, Maciej and Weniger, Marc and Rohde, Marius and Kreuz, Markus and Loeffler, Markus and Schilhabel, Markus and yling, Martin and Hansmann, Martin-Leo and Hummel, Michael and Szczepanowski, Monika and Ammerpohl, Ole and Stadler, Peter F and ... and ICGC Breast Canc Consortium and ICGC MMML-Seq Consortium and Australian Pancreatic Canc Genome and ICGC PedBrain and ICGC Breast Cancer Consortium and Australian Pancreatic Cancer Genome Initiative and Onkologi och Patologi, MV and Lund University and Oncology and Pathology, MV and Lunds universitet
Nature, ISSN 0028-0836, 2013, Volume 500, Issue 7463, pp. 415 - 421
Journal Article
Oncotarget, ISSN 1949-2553, 2011, Volume 2, Issue 3, pp. 251 - 258
Journal Article
International Journal of Cancer, ISSN 0020-7136, 08/2016, Volume 139, Issue 3, pp. 647 - 656
Journal Article
Nature, ISSN 0028-0836, 2017, Volume 543, Issue 7647, pp. 714 - 718
Journal Article
Clinical Epigenetics, ISSN 1868-7075, 10/2018, Volume 10, Issue 1, pp. 128 - 128
In this letter, we respond to and discuss the recent publication by Al-Moghrabi et al.: Methylation of BRCA1 and MGMT genes in white blood cells are... 
White blood cells | Constitutive methylation | Breast cancer | BRCA1 | Hypermethylation | Ovarian cancer | PROMOTER METHYLATION | RISK | OVARIAN-CANCER | VARIANT | BREAST-CANCER | ONCOLOGY | BLOOD-CELLS | Neonates | BRCA1 protein | Blood cells | DNA methylation | Epigenetics | Leukocytes | Methylation | Health risk assessment | Maternal transfer | Index Medicus
Journal Article